BridgeBio have substantially advanced its course of the innovative therapy for ATTR-CM, utilizing the investigational drug. Early clinical data reveals promising improvements for individuals affected by this severe https://bridgebio863910.canariblogs.com/bridgebio-improves-cardiac-amyloidosis-treatment-with-attruby-57094910